Additionally, it was found that in the 5×FAD AD mouse, this TAT-TrkB peptide improved cognitive ability, improved synaptic plasticity defects, and prevented Tau pathological progression in vivo [89]. The gene discussed is MAPT; the disease is Alzheimer disease.